Genpact Limited Stock Price and Value Analysis

Genpact Limited (NYSE:G) in our automated value investing analysis, with the cash flow history and price comparison below.

Key Facts

Advertisement helps keep Trendshare free for most readers.

Hold-time calculator

Estimate how long you need to hold Genpact Limited to reach your target.

Target type

G Free Cash Flow Trend

Free Cash Flow trendline for G
Free Cash Flow trendline for Genpact Limited
CSV

Based on historical returns, we believe that Genpact Limited can grow its free cash at a rate of about 9%. That's positive!

AdvantagesDisadvantages
  • This company has an average dividend yield.
  • This company has stable growth.
  • This company is making money at a decent rate.
  • This stock is on sale.
  • This company is less known than others.

Inside the G Numbers

G Price
(Genpact Limited stock price per share)
$41.50
[?] G Fair Price
(based on intrinsic value)
$64.13
[?] G Safety Price (based on a variable margin of safety) $38.48
Try your own return

The fair price above uses a 10.1% discount rate, the long-run US stock return (10.1% geometric, 1926 to 2025, from Bessembinder's working paper, updated 2026-11-09), and 2.5% terminal growth. A higher rate suits a higher return target and gives a lower value.

Value per share:

[?] PE Ratio versus Sector 7% lower than other Industrials stocks
[?] PE Ratio versus Industry 25% higher than other Consulting Services stocks
[?] Cash Yield 5.20%
[?] Free Cash Flow Jitter 24%
[?] Dividend Yield 1.79% (tax impact)
Shares Shorted 10,683,874

Insider Activity Summary

No open-market insider buys or sells are recorded for the last 12 months.

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 10,683,874 shares shorted. With 151,857,163 shares available for purchase and an average trading volume over the past 10 trading days of 2,469,240, it would take at least 4.3 days for all of the short holders to cover their shorts.

Related guides: good annual rate of return · high-yield stocks · forecasting earnings growth

Free Cash Flow by Fiscal Year

How to read this: free cash flow in plain terms, free cash flow jitter.

Each year names the SEC filer that reported it, so a change of filer shows up here.

Fiscal yearSEC filer (CIK)Free cash flow (USD millions)
2008 1398659 149
2009 1398659 101
2010 1398659 106
2011 1398659 215
2012 1398659 253
2013 1398659 256
2014 1398659 215
2015 1398659 269
2016 1398659 278
2017 1398659 297
2018 1398659 270
2019 1398659 356
2020 1398659 510
2021 1398659 626
2022 1398659 377
2023 1398659 430
2024 1398659 553
2025 1398659 749

Download the yearly data as CSV.

Cash Conversion

How to read this: what free cash flow is, why earnings matter.

Over the 18 fiscal years from 2008 to 2025 with positive net income, operating cash flow totaled $7,134 million against net income of $5,267 million, or 1.35 times.

In 2025, operating cash flow was 1.47 times net income, compared with 1.35 times for the earliest three years (2008 to 2010).

In 2025, capital expenditures were $78.2 million, 9.6% of operating cash flow of $813 million, which leaves an estimated $735 million after capex. Across the 18 years with reported capex, it averaged 16.2% of operating cash flow. This uses that year's own capital expenditures, not the five-year average behind the free cash flow table, so the two can differ.

Fiscal yearNet income (USD millions)Operating cash flow (USD millions)Capital expenditures (USD millions)Operating cash flow / net income
2008 125 211 62.4 1.69
2009 127 158 52.5 1.24
2010 142 163 55.2 1.15
2011 184 267 35.8 1.45
2012 178 311 83.3 1.74
2013 230 312 48.9 1.36
2014 192 272 62.6 1.42
2015 240 327 62.2 1.37
2016 270 346 81.9 1.28
2017 263 359 57.2 1.36
2018 282 340 85 1.20
2019 305 428 74.9 1.40
2020 308 584 70.2 1.90
2021 369 694 53.3 1.88
2022 353 444 50.6 1.26
2023 631 491 55.4 0.78
2024 514 615 82.8 1.20
2025 552 813 78.2 1.47

Where the Cash Went

How to read this: why companies buy back shares, dividend yield explained.

Over the 10 fiscal years from 2016 to 2025 with dividend or share repurchase facts, estimated free cash flow totaled $4,445 million. That estimate uses the average of up to five years of capital expenditures, not each year's own, so it is not a reported figure.

In the 9 of those years with dividend payment facts, dividends paid totaled $741 million, 17.8% of the estimated free cash flow of those years. Estimated free cash flow was at least the dividends paid in 9 of those 9 years.

In 10 of the 10 years, cash spent repurchasing shares was at least 5% of that year's estimated free cash flow, and in those years it totaled $2,160 million. Smaller amounts are left out of this sentence because they can be shares withheld to pay employees' taxes on stock awards.

In 2025, dividends and cash spent repurchasing shares together were $401 million, 53.5% of estimated free cash flow of $749 million.

Fiscal yearEstimated free cash flow (USD millions)Dividends paid (USD millions)Cash spent repurchasing shares (USD millions)Total returned (USD millions)Total as a percent of estimated free cash flow
2016 278 n/a 345 345 124.2%
2017 297 46.7 220 266 89.9%
2018 270 57.1 154 211 78.3%
2019 356 64.7 30 94.7 26.6%
2020 510 74.2 137 211 41.4%
2021 626 80.5 298 379 60.5%
2022 377 91.8 214 306 81.2%
2023 430 100 225 326 75.7%
2024 553 108 253 361 65.3%
2025 749 118 283 401 53.5%

Free cash flow here is an estimate: operating cash flow less the average of up to five years of capital expenditures. Cash spent repurchasing shares can include shares withheld to pay employees' taxes on stock awards. The entry n/a means the filings gave no usable figure, not that the amount was zero. Source: the company's annual reports to the SEC.

Revenue and Cash Margin

How to read this: earnings and margins.

Revenue was $1,041 million in 2008 and $5,080 million in 2025, a compound annual growth rate of 9.8% over 17 years.

Revenue rose 6.6% from 2024 to 2025.

Our estimated free cash flow was $749 million in 2025, 14.7% of revenue. In 2008 the estimated margin was 14.3%. This estimate charges each year with the average of up to five years of capital expenditures, so it is not the free cash flow the company reported.

Fiscal yearRevenue (USD millions)Estimated free cash flow (USD millions)Estimated free cash flow / revenue
2008 1,041 149 14.3%
2009 1,120 101 9.0%
2010 1,259 106 8.5%
2011 1,600 215 13.4%
2012 1,902 253 13.3%
2013 2,132 256 12.0%
2014 2,279 215 9.4%
2016 2,571 278 10.8%
2017 2,737 297 10.8%
2018 3,001 270 9.0%
2019 3,521 356 10.1%
2020 3,709 510 13.8%
2021 4,022 626 15.6%
2022 4,371 377 8.6%
2023 4,477 430 9.6%
2024 4,767 553 11.6%
2025 5,080 749 14.7%

Balance Sheet

How to read this: how debt and assets are compared, the current ratio.

In 2025, cash and equivalents were $854 million against total liabilities of $3,294 million, or 25.9% of total liabilities. Total liabilities include everything the company owes, not only borrowed money.

Total liabilities were 56.4% of total assets in 2025, compared with 31.3% in 2009, an increase of 25.0 percentage points.

Stockholders equity was $2,549 million in 2025, compared with $1,200 million in 2009, a rise of 112.5%.

Based on our estimated free cash flow, cash flow return on invested capital (CROIC) was 22.1% in 2025. Invested capital here is total assets less cash and current liabilities.

Fiscal yearTotal assets (USD millions)Cash and equivalents (USD millions)Total liabilities (USD millions)Stockholders equity (USD millions)
2009 1,748 289 548 1,200
2010 1,893 404 412 1,481
2011 2,403 408 968 1,436
2012 2,606 459 1,434 1,172
2013 2,689 571 1,365 1,324
2014 2,743 462 1,457 1,285
2015 2,793 451 1,489 1,304
2016 2,886 423 1,595 1,287
2017 3,450 504 2,021 1,424
2018 3,529 368 2,125 1,404
2019 4,454 467 1,076 1,689
2020 4,874 680 3,039 1,834
2021 4,975 899 3,078 1,897
2022 4,589 647 2,763 1,826
2023 4,806 584 2,557 2,248
2024 4,987 648 2,598 2,390
2025 5,843 854 3,294 2,549

What the Price Implies

How to read this: discounted cash flow, intrinsic value.

At today's price of $41.50, our model's value equals that price if free cash flow grows an average of 1.0 percent a year over the 10 projection years. Our model assumes 9.5 percent a year for this stock, so the price implies growth of 1.0 percent, which is below the 9.5 percent our model assumes. This is the growth the price implies under our model, not a forecast of growth or a price target.

The table shows the same calculation at a price 20 percent lower and 20 percent higher than today's price, and the model's own growth rate at its fair price.

The model starts from the company's average free cash flow of $361 million, grows it over 10 years along the year-by-year growth path stored for this stock (the pace fades over the years, and the implied rate keeps that shape, so the rates here are 10-year averages), discounts it at 10.1 percent a year, adds a terminal value that grows 2.5 percent a year after year 10, adds the company's net worth, and divides by shares outstanding.

The baseline is the company's average free cash flow, and cyclical companies can mislead it.

CasePrice per shareAverage annual free cash flow growth
20 percent below the current price $33.20 -4.2%
Current price $41.50 1.0%
20 percent above the current price $49.80 4.8%
Our model (stored fair price) $64.13 9.5%

Model assumptions: 10.1 percent discount rate, 2.5 percent terminal growth, 10 projection years. To try your own growth rate, use the intrinsic value calculator on this page. It uses a simpler single-rate model, so its results will not match the figures above exactly.

Price Versus Our Estimated Value

Every one of the 18 fiscal years we have for Genpact Limited under its current filer shows positive free cash flow.

Comparing the first and last three years of data, average free cash flow rose sharply: $119 million at the start and $577 million most recently.

Year-to-year variability in free cash flow is fairly steady, measured at 24%.

Genpact Limited at $41.50 lies between its safe value ($38.48) and its fair value ($64.13).

Genpact Limited yields 1.79% in dividends.

These numbers change when new filings or prices arrive, so treat this page as a snapshot and check the company's own filings.

Compared With Its Sector and Industry

How to read this: the price to earnings ratio.

Its trailing P/E ratio is 7% below the average for stocks in the Industrials sector.

Its trailing P/E ratio is 25% above the average for stocks in the Consulting Services industry.

A P/E ratio depends on trailing earnings, which one-time items can distort, so a lower P/E is not by itself evidence of value.

Closest Industry Peers

These are companies in the Consulting Services industry, the ones closest in market capitalization to Genpact Limited, limited to companies whose pages we publish. The figures come from our latest data for each company.

CompanyMarket cap (USD millions)P/EDividend yieldCash yieldPrice versus our estimate
Genpact Limited (G) 6,940 12.1 1.8% 5.2% 35% below
FTI Consulting (FCN) 5,605 25.6 - 2.7% 26% above
Exponent (EXPO) 4,240 38.4 1.4% 1.4% 13% above
Booz Allen Hamilton Holding Corporation (BAH) 9,803 12.8 2.8% 3.6% 7% above
ICF International (ICFI) 1,392 14.6 0.7% 7.9% 53% below
The Hackett Group (HCKT) 312 18.2 3.9% 11.5% 80% below
The RMR Group (RMR) 272 25.9 11.0% - 21% above

Industry labels are approximate, and companies in one industry can run quite different businesses, so a peer may not be a close match.

Ratios on different fiscal calendars are not strictly comparable, and a trailing P/E can be distorted by one-time items.

SEC Filer History

Every fiscal year on this page is reported by one SEC filer, CIK 1398659.

Each figure on this page comes from that filer.

Risks to This Analysis

How to read this: understanding investment risk.

  • These figures are automated calculations from SEC filings and the recent price. They may contain errors, and they do not reflect lawsuits, management changes, or other events the filings do not show.

How This Page Is Made

Latest annual report used
Fiscal year 2025
Price and market data last refreshed
2026-11-20
Model assumptions last reviewed
2026-11-09

Company figures come from the annual reports (Form 10-K) that each company files with the SEC, read from the SEC EDGAR company facts data. The share price and other market data come from a market data provider.

Free cash flow here is operating cash flow minus capital spending. To keep one unusual year from swinging the result, each year is charged with the average of up to five years of capital spending, so the figure is an estimate and not the free cash flow a company reports.

The fair price is the present value of ten years of projected free cash flow plus a terminal value, discounted at 10.1 percent a year, the long-run return of US stocks, with 2.5 percent growth after year ten. The figures on this page are estimates, not advice.

This analysis covers US companies that file 10-K annual reports. Free cash flow describes banks, real estate investment trusts and funds poorly, so treat their figures with extra caution. In the cash returned and balance sheet tables, a value of zero is treated as a gap in the data, not as a real zero.

Read the filings yourself: G annual reports (10-K) on SEC EDGAR. To try your own growth rate, use the intrinsic value calculator on this page. Our editorial standards explain how Trendshare handles its sources and corrections.

Advertisement supports free stock analysis content.

Questions to Answer Before You Invest in G

Does Genpact Limited have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.

Worked example: G

This example shows how we apply the Trendshare checklist to G: earnings power, cash generation, valuation, and margin of safety.

We check: business quality, free cash flow, P/E, and margin of safety.

  1. Step 1 — Snapshot

    • Price: 41.50
    • Market cap: $6.9B
    • EPS: 3.43
  2. Step 2 — Valuation checks

    • P/E: 12.099
    • FCF yield: 5.2%
    • Date checked: Nov 20, 2026
  3. Step 3 — Margin of safety

    • Compare price to fair value and safety price.
    • Look for durable cash generation and reasonable leverage.
    • Decide if it passes your personal checklist.